Skip to content
Terms & Conditions
Takeda Reports Results of Entyvio (vedolizumab SC) in P-III VISIBLE 2 Study for Moderately to Severely Active Crohn’s Disease
Celgene’s Otezla (apremilast) Receives FDA’s Approval for Oral Ulcers Associated with Behçet’s Disease
Sandoz Reports Patient Enrollment in P-I/III ROSALIA Study of Proposed Biosimilar Denosumab for Postmenopausal Osteoporosis
Gilead Signs an Exclusive Worldwide License Agreement with Novartis for its Three Preclinical Antiviral Programs
Amgen and Allergan Report Availability of Mvasi (biosimilar bevacizumab) and Kanjinti (biosimilar trastuzumab) in the US
Top 20 Diagnostics Companies Based On 2018 Revenue
Insights+ Key Biosimilars Events of June 2019
Subscribe To Our News Alert
Join our mailing list to receive the latest news and updates from PharmaShots.
You have Successfully Subscribed!